0001759425-20-000001.txt : 20201217 0001759425-20-000001.hdr.sgml : 20201217 20201216190913 ACCESSION NUMBER: 0001759425-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201216 EFFECTIVENESS DATE: 20201217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383478 FILM NUMBER: 201393781 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001505512 Regulus Therapeutics Inc. 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA CALIFORNIA 92121 858-202-6300 DELAWARE None None Corporation true Joseph Hagan c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Executive Officer Director Cris Calsada c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Executive Officer Christopher Aker c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Executive Officer Denis Drygin c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Executive Officer Stelios Papadopoulos c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director David Baltimore c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Kathryn J. Collier c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Jake R. Nunn c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director William H. Rastetter c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Hugh Rosen c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Simos Simeonidis c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Pascale Witz c/o Regulus Therapeutics Inc. 10628 Science Center Drive, Suite 225 San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-04 false true true true false 0 H. C. Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO CT CONNECTICUT MD MARYLAND NY NEW YORK OH OHIO TX TEXAS false 34537555 19383037 15154518 "Total Offering Amount" includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's Common Stock (assuming no cashless exercise). false 18 1066067 0 0 false Regulus Therapeutics Inc. /s/ Christopher Aker Christopher Aker Sr. VP and General Counsel 2020-12-14